※ Cumulative through Aug 1, 2026, vs. same period last year
PHIL INTER PHARMA USA, INC. shipped 104 cases to Korea in 2026, up 20% from the same period last year (87 cases). Main origins: United States of America.
Top exported products: POST GREEN RTG OMEGA3 PREMIUM 4 cases (up 100%), BRAIN 1088 4 cases (up 300%), THE FINE GINKGO MAG SINSIA 4 cases (new — no prior-year record).
Top importers: Koseumopam Co., Ltd. 19 cases (up 138%), Dongsin Healthcare Co., Ltd. 10 cases (up 43%), Welriseuon Co., Ltd. 9 cases (up 29%).
| Product | Shipments | vs. last year |
|---|---|---|
| POST GREEN RTG OMEGA3 PREMIUM | 4 | ▲ +100% |
| BRAIN 1088 | 4 | ▲ +300% |
| THE FINE GINKGO MAG SINSIA | 4 | New |
| DEEP SEA PHOSPHATIDYLSERINE GINKGO PLUS | 3 | ▲ +50% |
| GINKGOMESIA R-TG OMEGA GOLD | 2 | ▲ +100% |
| Importer | Shipments | vs. last year |
|---|---|---|
| Koseumopam Co., Ltd. | 19 | ▲ +138% |
| Dongsin Healthcare Co., Ltd. | 10 | ▲ +43% |
| Welriseuon Co., Ltd. | 9 | ▲ +29% |
| Medi ESI | 7 | ▼ -22% |
| Sion Medical Co., Ltd. | 7 | ▼ -12% |
| Country | Shipments | vs. last year |
|---|---|---|
| United States of America | 104 | — |
Is this your company? Claim your profile and let Korean buyers find you on TAAMs →